Return to homepagePandemic Pact

COVID19-MITC Trial Nation - COVID-19 Multiplying Infectious Disease Trial Capacity

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Innovationsfonden Denmark

  • Research Location

    Denmark

  • Lead Research Institution

    Trial Nation, Region Hovedstaden, Region Sjælland, Region Syd, Region Midtjylland, Region Nord.

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Therapeutic trial design

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

By increasing the capacity for clinical trials in six highly experienced clinical trials that form the center of infectious disease and immune modulation, the goal of the project is to multiply the number of clinical trials that the clinical trials can perform. Through the investment from the Innovation Fund, the project will increase capacity, infrastructure and national coordination for clinical trials, which provides agility and can increase the number of trials that the clinical trial units will be able to initiate - while maintaining quality.